Squarepoint
ALT icon

Squarepoint’s Altimmune ALT Stock Holding History

Squarepoint’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26,600
Closed -$112K – 3525
2023
Q1 		$112K Buy
+26,600
New +$316K ﹤0.01% 2948

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Squarepoint's ALT Position: Q2 2026 in Review

Squarepoint increased its Altimmune (ALT) stake by 1,017% in Q2 2026, buying an estimated $550K and bringing the position to 202,380 shares worth $615K. The position accounts for ﹤0.01% of the portfolio, ranked #3265.

Squarepoint first reported a position in ALT in Q3 2016 and has held it in 23 quarters since. The position peaked at $2.2M in Q3 2025. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Squarepoint held 202,380 shares of Altimmune worth $615K as of Q2 2026.
  • Squarepoint bought 184,254 Altimmune shares in Q2 2026, an estimated $550K.
  • Altimmune made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3265 holding.
  • Squarepoint first reported a position in Altimmune in Q3 2016 and has held it in 23 quarters since.
  • Squarepoint's Altimmune position peaked at $2.2M in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.